relative to consumer protection, transparency, and oversight of certain health care transactions and establishing a study committee to analyze health insurance providers, their practices, policies, premiums, management, and the impact to consumers.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 4 Sponsors 7

Mar 6, 2026 · Senate

Refer to Interim Study, MA, VV; 03/12/2026; SJ 6

Mar 4, 2026 · Senate

Committee Report: Referred to Interim Study, 03/12/2026; Vote 5-0; CC; SC 9

Feb 11, 2026 · Senate

Hearing: 02/18/2026, Room 100, SH, 09:00 am; SC 6

Feb 4, 2026 · Senate

Introduced 01/29/2026 and Referred to Health and Human Services; SJ 3

PASSAGE PROBABILITY

16% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -2 42/100 from the pace of recorded action
Time since last action -22 218 days quiet
Cosponsors +8 6 signed on
Sponsor influence +5 97/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.